(Q39840977)

15 September 2017

title

Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial (English)

1 reference

15 September 2017

Norfloxacin Therapy for Hepatopulmonary Syndrome: A Pilot Randomized Controlled Trial (English)

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

6 July 2024

main subject

hepatopulmonary syndrome

1 reference

Samir Gupta

1

1 reference

15 September 2017

Les Lilly

3

1 reference

15 September 2017

Stuart Hutchison

4

1 reference

15 September 2017

Robert Fowler

5

1 reference

15 September 2017

Marie E. Faughnan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816858

6 July 2024

Ahmed M. Bayoumi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816858

6 July 2024

language of work or name

English

0 references

publication date

9 November 2010

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:S1542356510008402?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

https://api.elsevier.com/content/article/PII:S1542356510008402?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Clinical Gastroenterology and Hepatology

6 July 2024

published in

1 reference

15 September 2017

volume

8

1 reference

15 September 2017

issue

12

1 reference

15 September 2017

page(s)

1095-1098

1 reference

Hepatopulmonary syndrome--a liver-induced lung vascular disorder

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Pentoxifylline attenuation of experimental hepatopulmonary syndrome.

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis.

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations.

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma.

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

6 July 2024

ATS Statement

13

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Pilot study of pentoxifylline in hepatopulmonary syndrome

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Improved survival after liver transplantation in patients with hepatopulmonary syndrome

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Hepatopulmonary syndrome: more than just a matter of tone?

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

A randomized controlled trial of acarbose in hepatic encephalopathy

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2010.08.011

6 July 2024

Identifiers

1 reference

15 September 2017

1 reference